Genflow Biosciences plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was GBP 0.621539 million compared to GBP 0.773794 million a year ago. Basic loss per share from continuing operations was GBP 0.0021 compared to GBP 0.00267 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 GBX | 0.00% | -6.25% | +57.89% |
Jun. 27 | EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens | AN |
Jun. 27 | Genflow Biosciences plc Announces Strengthening of Pre-Clinical Efforts | CI |
1st Jan change | Capi. | |
---|---|---|
+57.89% | 10.22M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- GENF Stock
- News Genflow Biosciences plc
- Genflow Biosciences plc Reports Earnings Results for the Half Year Ended June 30, 2023